Re: Neutralizing antibodies to interferon beta: assessment of their clinical and radiographic impact: an evidence report: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
Pachner
Andrew R
AR
D000906:Antibodies / Q000032:analysis / Q000276:immunology* / Q000378:metabolism; D001681:Biological Assay / Q000592:standards; D004351:Drug Resistance / Q000276:immunology; D019317:Evidence-Based Medicine; D005786:Gene Expression Regulation / Q000187:drug effects / Q000276:immunology; D006801:Humans; D016899:Interferon-beta / Q000037:antagonists & inhibitors* / Q000276:immunology*; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000276:immunology*; D017410:Practice Guidelines as Topic / Q000592:standards; D017211:Treatment Failure
D000906:Antibodies; D016899:Interferon-beta